Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.70 |
| ▸ | HPGD | P15428 | 5/20 | 0.70 |
| ▸ | FBP1 | P09467 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.70 |
| ▸ | DRD2 | P14416 | 1/20 | 0.70 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.70 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.70 |
| ▸ | DRD1 | P21728 | 1/20 | 0.70 |
| ▸ | MC5R | P33032 | 1/20 | 0.70 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.70 |
| ▸ | DRD3 | P35462 | 1/20 | 0.70 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.70 |
| ▸ | CCR2 | P41597 | 1/20 | 0.70 |
| ▸ | HTR6 | P50406 | 1/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.70 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzothiazyl Disulfide SCHEMBL11095350 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL30005981 | 0.83 | ALDH1A1 (0.76) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL29356396 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL23527 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL381557 | 0.83 | ALDH1A1 (0.76) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL9799786 | 0.81 | ALDH1A1 (0.73) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL8609896 | 0.81 | ALDH1A1 (0.96) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL3787918 | 0.81 | ALDH1A1 (0.96) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL1876191 | 0.80 | HPGD (0.66) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL7936041 | 0.80 | ALDH1A1 (0.85) | ALDH1A1HSD17B10HPGDFBP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100021480-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2010-01-28 | — | — | US | claimed |
| EP-1948676-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | Peptron Co., Ltd. (KR) | 2008-07-30 | — | — | EP | claimed |
| WO-2007049941-A1 | BIOACTIVE SUBSTANCE CARRIER FOR IN VIVO STABLE DELIVERY TEHREOF, CONJUGATE CONTAINING THE SAME, AND METHOD OF IN VIVO STABLE DELIVERY OF THE BIOACTIVE SUBSTANCE | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | claimed |
| WO-2007049940-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | claimed |
| WO-2000030632-A1 | ARYL AND HETEROARYL COMPOUNDS USEFUL AS FIBROBLAST GROWTH FACTOR ANTAGONISTS | EISAI CO., LTD. (JP) | 2000-06-02 | — | — | WO | claimed |
| US-20100021480-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2010-01-28 | — | — | US | disclosed |
| EP-1948676-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | Peptron Co., Ltd. (KR) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007049941-A1 | BIOACTIVE SUBSTANCE CARRIER FOR IN VIVO STABLE DELIVERY TEHREOF, CONJUGATE CONTAINING THE SAME, AND METHOD OF IN VIVO STABLE DELIVERY OF THE BIOACTIVE SUBSTANCE | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | disclosed |
| WO-2007049940-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | disclosed |
| WO-2000030632-A1 | ARYL AND HETEROARYL COMPOUNDS USEFUL AS FIBROBLAST GROWTH FACTOR ANTAGONISTS | EISAI CO., LTD. (JP) | 2000-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100021480-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | SERPINA6, CSTB, PLG | ALDH1A1 1756/4885HSD17B10 3063/4885HPGD 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.